Zamora, Geraldine B.
HRN: 21-16-98 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/20/2022
METRONIDAZOLE 500MG (TAB)
04/20/2022
04/26/2022
ORAL
500mg
Q8hours
IUFD
Waiting Final Action
Indication: Empiric Then Culture-directed Type of Infection: Urinary TractReproductive Tract Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes